News and Events

2016 Press Release Archive

November 12, 2016

Leap Therapeutics Presents Data from Phase 1 Study of GITR Agonist. Click here for full article

October 8, 2016

Leap Therapeutics Presents Positive Top-line Results of DKN-01 Combination Therapy for Cholangiocarcinoma at the European Society for Medical Oncology 2016 Congress. Click here for full article

August 29, 2016

Leap Therapeutics and Macrocure Announce Definitive Merger Agreement. Click here for full article

June 30, 2016

Leap Therapeutics Presents Positive Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer. Click here for full article

June 5, 2016

Leap Therapeutics Presents Data from Phase 1 Single Dose Safety Study of anti-GITR immunotherapy TRX518 in Patients with Advanced Relapsed or Refractory Solid Tumors at American Society of Clinical Oncology (ASCO) 2016 Annual Meeting.  Click here for full article

January 21, 2016

Leap Therapeutics Presents Positive Data from Phase 1 Study of DKN-01 in Combination with Paclitaxel in Relapsed or Refractory Cancer of the Esophagus or Gastroesophageal Junction.  Click here for full article

January 5, 2016

Leap Therapeutics Presents Data from Phase 1 Single Dose Safety Study of anti-GITR immunotherapy TRX518 in Patients with Advanced Relapsed or Refractory Solid Tumors at American Society of Clinical Oncology (ASCO) 2016 Annual Meeting. Click here for full article

Twiter Icon.png

© 2019 Leap Therapeutics, Inc.       All Rights Reserved